feed,title,long_url,short_url
BioRxiv,"The substitutions L50F, E166A and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitor in vitro and confer resistance to nirmatrelvir",https://biorxiv.org/cgi/content/short/2022.06.07.495116v1?rss=1,https://bit.ly/3mJk8rb
BioRxiv,Development of an Escape-resistant SARS CoV-2 Neutralizing Synthetic Nanobody,https://biorxiv.org/cgi/content/short/2022.06.07.495065v1?rss=1,https://bit.ly/3xsLW96
